معرفی
Dr. Philip Choi is an Adjunct Clinical Associate Professor at Monash University's Eastern Health Clinical School. His expertise spans stroke medicine, neurology, and clinical trials, with a focus on thrombolytic therapies and emergency stroke care. He holds a PhD in Medicine from Flinders University (2024), focusing on acute ischaemic stroke assessment.
Key projects include leading a phase 3 trial evaluating Momelotinib for myelofibrosis and a longitudinal study on secondary cerebrovascular events post-TIA. He has authored over 70 publications, with recent work focusing on tenecteplase efficacy in minor strokes, tranexamic acid in intracerebral haemorrhage, and DOAC rapid testing protocols.
- Research Interests: Stroke treatment protocols, thrombosis management, neuroimaging, clinical trial design, and post-stroke recovery.
- Recent Projects:
- TEMPO-2 trial (tenecteplase vs standard care for minor ischemic stroke)
- STOP-MSU trial (tranexamic acid in intracerebral haemorrhage)
- DOAC Dipstick consensus guidelines
- Grants & Funding: Active and completed projects supported by Pfizer and institutional funding.
His work contributes to UN Sustainable Development Goals related to health equity and neurological disorder management. Ongoing initiatives include developing stroke care platforms and optimizing rehabilitation pathways.
Philip Choi در سایتهای دیگر
جستوجوهای مرتبط
شاید اینها هم برایتان مناسب باشند
- LLesley CalaThe University of Western Australia · استاد بالینی
- TThalia FieldUniversity of British Columbia · دانشیار
- XXuya HuangUniversity of Glasgow · دانشیار بالینی
- MMartin KrauseUniversity of Sydney · دانشیار بالینی
- OOladi S BenthoUniversity of Minnesota Twin Cities · دانشیار
- LLouisa Marguerite ChristensenUniversity of Copenhagen · دانشیار بالینی